Cancer Genetics beats by $0.10, beats on revenue

|About: Cancer Genetics, Inc. (CGIX)|By:, SA News Editor

Cancer Genetics (CGIX): FQ3 EPS of -$0.61 beats by $0.10.

Revenue of $1.7M beats by $0.1M. (PR)